CA
SGEN

Centerpoint Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Centerpoint Advisors’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35
Closed -$7K – 624
2023
Q3 		$7K Hold
35
– – ﹤0.01% 369
2023
Q2 		$7K Hold
35
– – ﹤0.01% 375
2023
Q1 		$7K Hold
35
– – ﹤0.01% 379
2022
Q4 		$4K Hold
35
– – ﹤0.01% 367
2022
Q3 		$5K Hold
35
– – ﹤0.01% 272
2022
Q2 		$6K Hold
35
– – ﹤0.01% 261
2022
Q1 		$5K Hold
35
– – ﹤0.01% 277
2021
Q4 		$5K Buy
+35
New +$5.86K ﹤0.01% 280

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Centerpoint Advisors's SGEN Position: Q4 2023 in Review

Centerpoint Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 35 shares — an estimated $7K sold.

Centerpoint Advisors first reported a position in SGEN in Q4 2021 and held it in 8 quarters. The position peaked at $7K in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Centerpoint Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Centerpoint Advisors sold 35 Seagen Inc. Common Stock shares in Q4 2023, an estimated $7K.
  • Centerpoint Advisors first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Centerpoint Advisors's Seagen Inc. Common Stock position peaked at $7K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Centerpoint Advisors's 13F filing for Q4 2023, filed 16 Jan 2024.